Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced that the Montreal Heart Institute has enrolled the first Canadian participant in its ReVeRA-301 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE